Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 08-2009 | 05-2009 | 02-2009 | 11-2008 | 08-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8 | 354 | 315 | 38 | 141 |
| Depreciation Amortization | 23 | 89 | 65 | 43 | 21 |
| Income taxes - deferred | N/A | -68 | N/A | N/A | N/A |
| Accounts receivable | 92 | -29 | -233 | 34 | 88 |
| Other Working Capital | 0 | -693 | -586 | -230 | -150 |
| Other Operating Activity | -88 | 244 | 219 | 31 | -50 |
| Operating Cash Flow | $35 | $-102 | $-220 | $-85 | $50 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 100 | -100 | -100 | N/A | N/A |
| PPE Investments | -25 | -86 | -76 | -60 | -33 |
| Purchase Sale Intangibles | -3 | -30 | N/A | N/A | N/A |
| Other Investing Activity | -3 | -30 | 0 | 0 | 0 |
| Investing Cash Flow | $72 | $-216 | $-176 | $-60 | $-33 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2 | N/A | N/A |
| Debt Issued | N/A | 133 | N/A | N/A | N/A |
| Debt Repayment | -10 | -273 | -134 | -122 | -108 |
| Common Stock Issued | N/A | 36 | 36 | 33 | 27 |
| Common Stock Repurchased | N/A | -3 | N/A | N/A | 3 |
| Financing Cash Flow | $-10 | $-107 | $-96 | $-88 | $-78 |
| Exchange Rate Effect | 0 | -2 | -1 | -2 | N/A |
| Beginning Cash Position | 1,596 | 2,022 | 2,022 | 2,022 | 2,022 |
| End Cash Position | 1,692 | 1,596 | 1,529 | 1,788 | 1,961 |
| Net Cash Flow | $96 | $-427 | $-493 | $-234 | $-62 |
| Free Cash Flow | |||||
| Operating Cash Flow | 35 | -102 | -220 | -85 | 50 |
| Capital Expenditure | -25 | -86 | -76 | -60 | -33 |
| Free Cash Flow | 10 | -188 | -296 | -145 | 17 |